MATHEW ABY J. (EVP & Chief Scientific Officer) reported 1 transaction at BIOLIFE SOLUTIONS INC
Review the transaction codes below to understand the nature of each event.
Filed: 6/10/2026ACC: 0001628280-26-042284
Officer· EVP & Chief Scientific Officer
Since Mar 2026
-627.00
Net shares
Net seller
$16.4K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
627.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−627.00
Price / share
$26.10
Trade value
$16.36K
% of position
0.2%
6/8/2026
390.17K→389.54K
Total
Net shares
−627.00
Net value
-$16.36K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/8/2026 | F · Tax Withholding | −627.00 | $26.10 | $16.36K | 0.2% | 390.17K | 389.54K |
| Total | −627.00 | -$16.36K | ||||||
Derivative Transactions0
No derivative transactions reported